UFP Technologies, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
UFP Technologies, Inc. (UFPT) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $6.25 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-06
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $6.25M.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $9.38M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $3.13M.
- 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $6.25M; Long-Term Debt, Maturity, Remainder of Fiscal Year as first filed $9.38M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year | Long-Term Debt, Maturity, Remainder of Fiscal Year as first filed |
|---|---|---|
| 2026-06-30 | $6.25M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.38M 10-Q · filed 2026-05-08 | |
| 2025-09-30 | $3.13M 10-Q · filed 2025-11-07 | |
| 2025-03-31 | $6.25M 10-Q · filed 2025-08-11 | $9.38M 10-Q · filed 2025-05-12 |
| 2024-09-30 | $3.13M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $3.00M 10-Q · filed 2024-05-10 | |
| 2023-09-30 | $1.00M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-10 | |
| 2022-09-30 | $1.00M 10-Q/A · filed 2022-11-14 | |
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.00M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |